On the contrary, breast cancers with increased CDK18 mRNA was associated with poor response to chemotherapeutic agents, inducing DNA replication stress, suggesting that CDK18 mRNA and protein levels are differently regulated with hypothetically distinct predictions on patients prognosis.468. Here, CDK18 is linked to breast carcinoma.